Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine

日本 ニュース ニュース

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine
日本 最新ニュース,日本 見出し
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 73 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 71%

Survey of previously vaccinated US residents finds the most common reasons for not getting an updated COVID-19 vaccine CDCgov DukeU GeorgiaTech vaccine covid COVID19 coronavirus SARSCoV2

By Bhavana KunkalikarJan 24 2023Reviewed by Danielle Ellis, B.Sc. In a recent study published in the Morbidity Mortal Weekly Report, researchers described reasons cited by adults for receiving or not receiving coronavirus disease 2019 booster vaccines.

Participants were enrolled through the online survey platform Prolific. Eligible participants were aged 18 years or older, proficient in English, US citizens, and vaccinated with one or more prior COVID-19 vaccines. To recruit almost equal proportions of adults aged between 18 and 39 years, 40 and 59 years, and 60 years and above, quota sampling was employed. Data collection was performed between 1 and 5 November and 6 and 10 December 2022.

Results The initial survey involved 1,200 individuals, with almost one-third of individuals classified in each age cohort. Almost 65% of the participants were White, while 51.9% were female. Most patients were vaccinated with two SARS-CoV-2 vaccine doses, including 396 vaccinated with the bivalent booster vaccine. Approximately 714 reported not receiving the bivalent booster vaccine. Almost 396 individuals vaccinated with the bivalent booster vaccine cited an average number of five reasons.

The most prevalent reasons cited by persons aged between 40 and 59 years were ignorance of eligibility or the belief that they were still adequately protected against severe COVID-19 disease or SARS-CoV-2 infection . The most prevalent reasons cited by people aged 60 years or older for not receiving a bivalent booster dose were the belief that they were still adequately protected against infection , anxiety about adverse effects , and uncertainty regarding the booster's efficacy .

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

NewsMedical /  🏆 19. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Researchers review the association between endogenous retrovirus reactivation and agingResearchers review the association between endogenous retrovirus reactivation and agingResearchers review the association between endogenous retrovirus reactivation and aging sbpdiscovery EndogenousRetrovirus Aging AntiAging
続きを読む »

Glasgow's favourite foods and drinks REVEALED by Just Eat surveyGlasgow's favourite foods and drinks REVEALED by Just Eat surveyAn in-house Just Eat survey has determined Glasgow's favourite takeaway food and drink.
続きを読む »

WHO’s 14th situation report for the multi-country outbreak of mpox overviews the clinical and public health links between HIV and mpoxWHO’s 14th situation report for the multi-country outbreak of mpox overviews the clinical and public health links between HIV and mpoxWHO’s 14th situation report for the multi-country outbreak of mpox overviews the clinical and public health links between HIV and mpox WHO mpox virus infection health HIV
続きを読む »

Researchers report a reduction in hospitalizations and deaths from SARS-CoV-2 infections during the Omicron variant-dominated wave in MalawiResearchers report a reduction in hospitalizations and deaths from SARS-CoV-2 infections during the Omicron variant-dominated wave in MalawiResearchers report a reduction in hospitalizations and deaths from SARS-CoV-2 infections during the Omicron variant-dominated wave in Malawi MlwTrust LivUni UofGlasgow LSHTM SARSCoV2 infection covid coronavirus covid Omicron
続きを読む »

Researchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccineResearchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccineResearchers identify potent pan-sarbecovirus antibodies from non-human primates vaccinated with an AS03 adjuvanted subunit SARS-CoV-2 vaccine biorxivpreprint Stanford scrippsresearch UNC ULLafayette vaccine vaccinated SARSCoV2
続きを読む »



Render Time: 2025-03-20 00:01:28